Independent HCP Publication Support (IHPS) supports authors publishing independent research in Novo Nordisk’s therapeutic areas to expand medical and scientific knowledge and potentially improve patient care.
The Investigator-Sponsored Studies (ISS) Program supports independent researchers conducting clinical and observational studies to address evidence gaps in Novo Nordisk therapeutic areas and improve patient outcomes.
Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator Sponsored Research Program supports independent investigators studying Medtronic products, services, and therapies to build clinical evidence and improve patient care.
Investigator-initiated trials (IITs) support independent investigators and academic sponsors conducting clinical and non-clinical research to advance knowledge about Lundbeck compounds and improve patients’ lives.
Investigator-Initiated Research (IIR) supports independent investigators with funding, study drug, or data and samples for research addressing unmet patient needs or important scientific questions.